Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
To warrant clinical adoption AI models require a multi-faceted implementation evaluation
41
Zitationen
6
Autoren
2024
Jahr
Abstract
Despite artificial intelligence (AI) technology progresses at unprecedented rate, our ability to translate these advancements into clinical value and adoption at the bedside remains comparatively limited. This paper reviews the current use of implementation outcomes in randomized controlled trials evaluating AI-based clinical decision support and found limited adoption. To advance trust and clinical adoption of AI, there is a need to bridge the gap between traditional quantitative metrics and implementation outcomes to better grasp the reasons behind the success or failure of AI systems and improve their translation into clinical value.
Ähnliche Arbeiten
Meta-analysis in clinical trials
1986 · 38.826 Zit.
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
2018 · 37.636 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 37.602 Zit.
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 · 33.599 Zit.
RoB 2: a revised tool for assessing risk of bias in randomised trials
2019 · 28.682 Zit.